Before you sell to, join or invest in Cytex Therapeutics, Inc.
MentionFox check on Cytex Therapeutics, Inc.: only 1 source on file so far (checked 6 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/cytex-therapeutics-inc-form-d-25000001
Check Cytex Therapeutics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Cytex Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-01-10.
Cytex Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on January 10, 2025. The filing reports $125K sold. Its industry group is Biotechnology. It names BRADLEY ESTES (Executive Officer, Director), FARSHID GUILAK (Executive Officer, Director), DAVID NOLAN (Director) (SEC Form D, January 10, 2025).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Cytex Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-01-10 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Cytex Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Cytex Therapeutics, Inc., from the filings we hold.
Biotechnology raises by companies based in North Carolina, filed within 90 days of this one, largest first.
Get an email when Cytex Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Cytex Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Cytex Therapeutics, Inc. →Get the full cited report on Cytex Therapeutics, Inc.
What the filing shows about Cytex Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Cytex Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Cytex Therapeutics, Inc.'s address as 2609 N. Duke Street, Suite 303A, Durham, NC 27704.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Cytex Therapeutics, Inc. See pricing
Cytex Therapeutics, Inc. is a registered filer with the SEC (CIK 1943908) and has filed since 2025-01-10. 1 filing is on record, the latest on 2025-01-10.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Cytex Therapeutics, Inc.'s Form D of 2025-01-10 names BRADLEY ESTES, FARSHID GUILAK, DAVID NOLAN and 2 more as its officers, directors or promoters.
Its new offerings report $125K sold across 1 offering, as its own filings state.
Trailing twelve months. 763 filings in Biotechnology, totalled by week.
Bradley Estes is named as Executive Officer and Director on the Form D that Cytex Therapeutics, Inc. filed with the SEC on 10 January 2025, one of 5 people that filing names.
Farshid Guilak is named as Executive Officer and Director on the Form D that Cytex Therapeutics, Inc. filed with the SEC on 10 January 2025, one of 5 people that filing names.
David Nolan is named as Director on the Form D that Cytex Therapeutics, Inc. filed with the SEC on 10 January 2025, one of 5 people that filing names.
Franklin Moutos is named as Executive Officer on the Form D that Cytex Therapeutics, Inc. filed with the SEC on 10 January 2025, one of 5 people that filing names.
Christine Estes is named as Executive Officer on the Form D that Cytex Therapeutics, Inc. filed with the SEC on 10 January 2025, one of 5 people that filing names.
5 people named on the filing — 4 holding an executive role and 1 as a director only.
Named as of the 2025-01-10 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Cytex Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Cytex Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cytex Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Cytex Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Cytex Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Cytex Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Raleigh-Durham
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/cytex-therapeutics-inc-form-d-25000001